Page last updated: 2024-11-04

sulfadiazine and Intellectual Disability

sulfadiazine has been researched along with Intellectual Disability in 1 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gilmour, SK1

Other Studies

1 other study available for sulfadiazine and Intellectual Disability

ArticleYear
Rebalancing polyamine levels to treat Snyder-Robinson syndrome.
    EMBO molecular medicine, 2023, 11-08, Volume: 15, Issue:11

    Topics: Humans; Intellectual Disability; Male; Mental Retardation, X-Linked; Mutation; Polyamines; Sulfadiaz

2023